Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care

被引：0
|
作者：
Munoz-Martinez, Sergio [1 ,2 ]
Jimenez-Masip, Alba [1 ,3 ]
Pericas, Juan M. [1 ,3 ,4 ]
机构：
[1] Vall dHebron Hosp Univ, Liver Unit, Vall dHebron Inst Recerca VHIR, Liver Unit, Pg Vall dHebron 119-129, Barcelona 08035, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 01期
关键词：
Metabolic-dysfunction associated steatotic liver disease (MASLD); advanced fibrosis; type 2 diabetes (T2D); non-invasive tests (NITs); OUTCOMES; NAFLD;
D O I：
10.21037/hbsn-23-563
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [1] Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
    Armandi, Angelo
    Bugianesi, Elisabetta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 20 - 27
  • [2] Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
    Xu, Qiuyu
    Zhang, Jie
    Lu, Yan
    Wu, Ling
    ISCIENCE, 2024, 27 (02)
  • [3] PARENTAL OBESITY AT PREGNANCY WITH RISK OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN YOUNG ADULT OFFSPRING
    Tica, Stefani
    Zong, Xiaoyu
    Tarr, Phillip I.
    Cao, Yin
    GASTROENTEROLOGY, 2024, 166 (05) : S26 - S27
  • [4] Impact of sexual dimorphism on liver damage in patients with metabolic-dysfunction associated steatotic liver disease
    Dileo, E.
    Rosso, C.
    Parasiliti-Caprino, M.
    Caviglia, G. P.
    Ponzetto, F.
    Leoni, L.
    Pennisi, G.
    Armandi, A.
    Guariglia, M.
    Saba, F.
    Maccario, M.
    Petta, S.
    Mengozzi, G.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [5] Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease
    Kalligeros, Markos
    Tsochatzis, Emmanuel A.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (02) : 311 - 313
  • [6] The importance of age for liver-related mortality in patients with metabolic-dysfunction associated steatotic liver disease
    Bjornsson, Einar S.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (01) : 124 - 127
  • [7] Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
    Vega, Luis
    Simian, Daniela
    Gajardo, Abraham I.
    Salinas, Marcelo
    Urra, Andrea
    Cattaneo, Maximo
    Pino, Rosario
    Roblero, Juan P.
    Urzua, Alvaro
    Rojas, Katherine
    Poniachik, Jaime
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [8] Investigating the postprandial metabolic and inflammatory phenotypes of healthy subjects and patients with metabolic dysfunction-associated steatotic liver disease and metabolic-dysfunction associated steatohepatitis to understand disease progression
    Mullin, Sinead M.
    Shannon, Christopher E.
    Ni Chathail, Meabh B.
    Singh, Pamla
    Norris, Suzanne
    Roche, Helen M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2024, 83 (OCE4)
  • [9] SCREENING FOR METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE AND ADVANCED FIBROSIS AMONG PATIENTS WITH OBESITY: A COST-EFFECTIVENESS ANALYSIS
    Mohanty, Arpan
    Wang, Yin
    Stoecker, Charles
    GASTROENTEROLOGY, 2024, 166 (05) : S1667 - S1667
  • [10] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
12345